news 6 min read
GPT-5 Reduces Cell-Free Protein Synthesis Costs by Orders of Magnitude in 2026
OpenAI's GPT-5 has achieved a breakthrough in biotechnology by reducing the cost of cell-free protein synthesis through AI-optimized reaction conditions. The development could accelerate drug discovery and make synthetic biology more accessible.
Alex Chen